Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 3 days agoThe Pfizer and GSK shots are available to people age 60 and older. Women can also get the Pfizer...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 4 days agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agoOne reason for Moderna’s low sales is because Americans aren’t getting booster vaccines as...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 7 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Health Freedom Prevails Against the CDC and NIH
Mercola· 22 hours agoIn the video above, Del Bigtree, founder of “The Highwire” and the Informed Consent Action Network (icandecide.org), shares some of the recent lawsuits ICAN has won against the National Institutes ...